Innovating pharmaceuticals for life

Vice President, Business Development

Andrew Serafin

Mr. Serafin is responsible for leading Marathon’s business development efforts, including the acquisition and in-licensing of new rare disease treatments into the company’s pipeline.

Mr. Serafin has 16 years’ experience in corporate legal counseling and mergers and acquisitions in the healthcare and technology sectors, including nine years of specialty pharmaceutical experience. Mr. Serafin previously served as vice president for M&A and legal affairs at AltaThera Pharmaceuticals and as vice president of U.S. legal affairs and associate general counsel at Lundbeck Inc., where he oversaw transactions with valuations of up to $1 billion.

Mr. Serafin began his career in private legal practice where he specialized in corporate transactions, provided strategic consulting and consummated both public and private deals, acquisitions and divestitures.

He holds a bachelor’s degree from the University of Illinois, MBA from the Kellogg School of Management at Northwestern University, and a J.D. from Loyola University Chicago School of Law.